📰 Cigna News
Page 502 - Cigna News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Cigna. Real-time updates on events, politics, business and more.
June 12, 2021
On June 7, 2021, the U.S. Food and Drug Administration (FDA) approved Biogen, Inc.'s Aduhelm (aducanumab) to treat Alzheimer's disease through the FDA Accelerated Approval Program in a...
June 12, 2021
Breaking New Jersey Business news headlines, linking to 1000s of sources around the world, on NewsNow: the one-stop shop for breaking news
June 11, 2021
Oscar CEO Mario Schlosser on what makes his pioneering insurtech startup stand out.
June 11, 2021
As per the report published by Allied Market Research, the global Dental Insurance Market is expected to exhibit a significant growth rate in between
June 11, 2021
/PRNewswire/ -- Success TMS, a leading provider of Transcranial Magnetic Stimulation (TMS) treatments, continues to open new locations around the country,...
June 11, 2021
Grocery store billionaire and Pittsburgh Penguins co-owner Ronald Burkle is getting into the sporting goods business. Burkle’s Yucaipa Acquisition, a SPAC that holds $345 million from an August IPO, has inked a deal to merge with Signa Sports United, a German-based online sporting goods retailer, according to a release from Signa. The deal, which values […]
June 10, 2021
New Alzheimer’s drug Aducanumab – cost, side effects, timeline and other questions answered Patients and their families are starting to inquire about the new Alzheimer’s drug approved this week by the US Food and Drug Administration. Shipments of the medication are expected to go out in just a couple of weeks. Hospitals are on tap to administer treatment when needed. And there is serious division in the FDA, especially around the drug’s effectiveness. Aducanumab, to be sold under the br...
June 10, 2021
Patients and their families are starting to inquire about the new Alzheimers drug approved this week by the US Food and Drug Administration.
June 10, 2021
New Alzheimer’s drug aducanumab: cost, side effects, timeline and other questions answered Patients and their families are starting to inquire about the new Alzheimer’s drug approved this week by the US Food and Drug Administration. Shipments of the medication are expected to go out in just a couple of weeks. Hospitals are on tap to administer treatment when needed. And there is serious division in the FDA, especially around the drug’s effectiveness. Aducanumab, to be sold under the brand...
June 10, 2021
This favorite of the retail crowd has something the others don't: growth and innovation.